Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Replacement re Issue of Equity

4 Jul 2014 16:32

RNS Number : 5460L
Maven Income & Growth VCT 4 PLC
04 July 2014
 

Maven Income and Growth VCT 4 PLC

 

Issue of Equity and Total Voting Rights - Replacement

 

The issuer advises that the following replaces the Maven Income and Growth VCT 4 PLC - Issue of Equity and Total Voting Rights announcement released at 09.50 BST on 2 July 2014.

 

At the end of the third paragraph in the announcement the number of Ordinary Shares allotted pursuant to the Offer and the number of additional Ordinary Shares allotted have now been identified separately, and the date on which dealings in shares is expected to commence has been revised to "on or around 8 July 2014".

 

The reference to the date of the announcement by the Board (of the postponement of the allotment of Ordinary Shares) has been corrected to state 30 April 2014.

 

All other details remain unchanged.

 

The full amended version is shown below.

 

On 24 October 2013, Maven Income and Growth VCT 4 plc (the "Company"), Maven Income and Growth VCT plc, Maven Income and Growth VCT 2 plc, Maven Income and Growth VCT 3 plc, Maven Income and Growth VCT 5 plc and Maven Income and Growth VCT 6 plc (together "the Companies") announced that they had published a Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares in each of the Companies to raise, in aggregate, up to £20 million (before issue costs) together with an over-allotment facility for up to a further £5 million, in aggregate (the "Offer").

 

In view of discussions between the VCT industry and HM Treasury regarding proposed changes to regulations contained in The Finance Bill 2014, which would have applied to VCT shares issued on or after 6 April 2014, the Company announced on 30 April 2014 that the Directors of the Company proposed to postpone the allotment of new Ordinary Shares under the Offer for the 2014/15 tax year until the Directors believed that there was certainty that allotments could take place without contravening the new rules. HM Treasury has clarified the operation of these new regulations to the Board's satisfaction and, on 28 May 2014, the Board announced that the Offer would close at 5.00 pm on 30 May 2014 unless fully subscribed by an earlier date, with the allotment and listing of the new Ordinary Shares occurring as soon as practicable thereafter. 

 

The Board now confirms that all valid applications in respect of the 2014/15 tax year have been accepted in full and in relation to the applications received the Company issued and allotted a further 548,108 Ordinary Shares of 10 pence each on 1 July 2014 at an offer price of 99.07p per Ordinary Share (533,929 of which were allotted to applicants pursuant the Offer and a further 14,179 of which were allotted to the same persons at the same offer price as a result of the delay in allotting those shares pursuant the Offer).

 

As a result of the further allotment the number of Ordinary Shares now in issue is 29,406,381, and the total voting rights of the Company, is 33,270,257.

 

Dealings in all the Ordinary Shares allotted are now expected to commence on or around 8 July 2014.

 

Since the publication of the Prospectus, in aggregate, 4,273,209 Ordinary Shares of 10 pence each have been issued by the Company in relation to the Offer, with net proceeds of £4.09 million being raised by the Company through the issue of those shares.

 

For further information please contact Maven Capital Partners UK LLP by telephone on 0141 306 7400 or by e-mail to enquiries@mavencp.com.

 

Maven Capital Partners UK LLP

Secretary

 

4 July 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOESSEFILFLSEDW
Date   Source Headline
20th May 202610:12 amRNSAdmission of Further Securities to Trading
15th May 202610:45 amRNSDirector/PDMR Shareholding
15th May 202610:41 amRNSIssue of Equity - Dividend Investment Scheme
14th May 20265:22 pmRNSTransaction in Own Shares
12th May 20263:37 pmRNSUnaudited NAV - Dividend Investment Scheme
7th May 20261:45 pmRNSResult of AGM
30th Apr 202610:58 amRNSAdmission of Further Securities to Trading
29th Apr 202612:29 pmRNSIssue of Equity
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:27 amRNSAdmission of Further Securities to Trading
14th Apr 202611:09 amRNSIssue of Equity
10th Apr 202612:02 pmRNSUnaudited Net Asset Value
8th Apr 20269:33 amRNSAdmission of Further Securities to Trading
25th Mar 20263:51 pmRNSTransaction in Own Shares
25th Mar 202610:55 amRNSAdmission of Further Securities to Trading
24th Mar 202612:11 pmRNSIssue of Equity
19th Mar 20264:21 pmRNSUnaudited NAV and Proposed Final Dividend
18th Feb 20264:58 pmRNSAdmission of Further Securities to Trading
17th Feb 202611:07 amRNSDirector/PDMR Shareholding
17th Feb 202611:07 amRNSDirector/PDMR Shareholding
17th Feb 202610:54 amRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
21st Jan 202611:07 amRNSAdmission of Further Securities to Trading
20th Jan 20262:05 pmRNSAdmission of Further Securities to Trading
16th Jan 20269:52 amRNSDirector/PDMR Shareholding
16th Jan 20269:44 amRNSIssue of Equity
15th Jan 202610:36 amRNSDirector/PDMR Shareholding
15th Jan 202610:35 amRNSDirector/PDMR Shareholding
15th Jan 20269:55 amRNSIssue of Equity
14th Jan 20262:39 pmRNSUnaudited NAV - Dividend Investment Scheme
13th Jan 202612:10 pmRNSUnaudited Net Asset Value
4th Dec 202510:35 amRNSSecond Interim Dividend
18th Nov 20253:48 pmRNSTransaction in Own Shares
14th Nov 20259:31 amRNSNet Asset Value(s)
13th Nov 20254:53 pmRNSResult of General Meeting
2nd Oct 20254:42 pmRNSPublication of a Prospectus
29th Aug 20257:00 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSIssue of Equity
29th Aug 20257:00 amRNSHalf-year Report
20th Aug 20252:14 pmRNSStatement re Dividend Investment Scheme
31st Jul 20254:42 pmRNSTransaction in Own Shares
16th Jul 202510:18 amRNSStatement re Unaudited NAV and Interim Dividend
16th Jul 20257:08 amRNSStatement re Offer for Subscription
21st May 20254:44 pmRNSTransaction in Own Shares
16th May 20259:30 amRNSDirector/PDMR Shareholding
16th May 20259:26 amRNSIssue of Equity - Dividend Investment Scheme
9th May 20251:53 pmRNSStatement re Dividend Investment Scheme
9th May 202510:03 amRNSNet Asset Value(s)
8th May 20251:43 pmRNSResult of AGM
6th May 202511:55 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.